NM_001173393.3:c.521C>A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001173393.3(HAVCR1):c.521C>A(p.Thr174Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00138 in 1,601,460 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T174M) has been classified as Benign.
Frequency
Consequence
NM_001173393.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000915 AC: 139AN: 151866Hom.: 0 Cov.: 35 show subpopulations
GnomAD2 exomes AF: 0.000753 AC: 188AN: 249610 AF XY: 0.000827 show subpopulations
GnomAD4 exome AF: 0.00143 AC: 2078AN: 1449474Hom.: 1 Cov.: 63 AF XY: 0.00136 AC XY: 983AN XY: 720882 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000915 AC: 139AN: 151986Hom.: 0 Cov.: 35 AF XY: 0.000821 AC XY: 61AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.521C>A (p.T174K) alteration is located in exon 3 (coding exon 3) of the HAVCR1 gene. This alteration results from a C to A substitution at nucleotide position 521, causing the threonine (T) at amino acid position 174 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at